Tina S. Ipe

Researcher

UAMS primary UA Little Rock

Also affiliated: Boston University (2005); Scripps Research Institute (2021); Children's Hospital of Philadelphia (2014); New York Blood Center (2014); Harvard University (2005); Massachusetts General Hospital (2005); Methodist Hospital (2015–2019); Methodist Hospital (2017–2019); Joint Research Center (2021); Center for Neuroscience and Regenerative Medicine (2024–2025); Oklahoma Blood Institute (2022–2024); Scripps Clinic (2021)

Faculty Researcher

15 h-index 56 pubs 758 cited

Research Areas

Biomedical Subjects

Links

ORCID Research Group

OverviewAI-generated summary

Dr. Tina S. Ipe's research focuses on transfusion medicine and the clinical applications of blood components. Her work has investigated therapeutic plasma exchange for conditions such as myasthenia gravis, as evidenced by her systematic literature review and meta-analysis. She has also examined the impact of global health crises, including COVID-19, on transfusion services in low- and middle-income countries and the productivity of female physicians in transfusion medicine. Dr. Ipe has been involved in clinical trials evaluating convalescent plasma for COVID-19 and the efficacy of pathogen-reduced red blood cells in complex cardiac surgery. Her scholarship includes a cross-sectional survey on hospital-based blood transfusion services in resource-limited settings. She has authored 56 publications, with an h-index of 15 and 747 citations. Key collaborators at the University of Arkansas for Medical Sciences include Horace J. Spencer, Anand N. Venkata, Ryan K Dare, and Juan Carlos Rico Crescencio.

Metrics

h-index: 15
Publications: 56
Citations: 758

Selected Publications

A low dose is better than no dose: Is it time to consider lowering the US minimum plateletpheresis yield? (2026)

Transfusion and Apheresis Science DOI OpenAlex
Current advances 2024: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (<scp>AABB</scp>) Clinical Transfusion Medicine Committee (2025)

Transfusion 1 citation DOI OpenAlex
Transfusion Efficacy and Safety of Amustaline/Glutathione Pathogen-Reduced Red Blood Cells: Results of a Randomized, Controlled Phase III Trial (2024)

Blood DOI OpenAlex
Plasma Adsorption with the MTx.100 Column in Critically Ill COVID-19 Patients: A Prospective Study and Propensity Score Analysis (2024)

Journal of Intensive Care Medicine 1 citation DOI OpenAlex
Current advances in 2024: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies ( <scp>AABB</scp> ) Clinical Transfusion Medicine Committee (2024)

Transfusion 2 citations DOI OpenAlex
A review and analysis of outcomes in randomized clinical trials of plasma transfusion in patients with bleeding or for the prevention of bleeding: The <scp>BEST</scp> collaborative study (2024)

Transfusion 6 citations DOI OpenAlex
Gender differences in scholarly productivity of early‐career transfusion medicine physicians (2024)

Vox Sanguinis 2 citations DOI OpenAlex
Evaluation of the efficacy and safety of amustaline/glutathione pathogen-reduced RBCs in complex cardiac surgery: the Red Cell Pathogen Inactivation (ReCePI) study—protocol for a phase 3, randomized, controlled trial (2023)

Trials 14 citations DOI OpenAlex
Evaluation of the Efficacy &amp; Safety of Amustaline/Glutathione Pathogen Reduced RBCs in Complex Cardiac Surgery: the Red Cell Pathogen Inactivation (ReCePI) Study - Protocol for a Phase 3, Randomized, Controlled Trial (2023)

Research Square DOI OpenAlex
Transfusion medicine research in Africa: Insights from investigators in the field (2023)

Vox Sanguinis 2 citations DOI OpenAlex
Cold stored platelets – Increasing understanding and acceptance (2023)

Transfusion and Apheresis Science 12 citations DOI OpenAlex
Academic Productivity of Early Career Transfusion Medicine Specialists: A Workforce Study (2022)

Transfusion Medicine Reviews 4 citations DOI OpenAlex
Incidence of Red Cell Antibody Formation Following Massive Transfusion Protocol: Experience of a Single Institution (2022)

The American Surgeon 1 citation DOI OpenAlex
Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19 (2022)

CHEST Journal 30 citations DOI OpenAlex
Treatment of COVID-19 Patients with Two Units of Convalescent Plasma in a Resource-Constrained State (2022)

Laboratory Medicine 1 citation DOI OpenAlex